Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects

NCT06584812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER_GOV

Sponsor class

Conditions

Acute Coronary Syndrome
Ischemic Stroke

Interventions

DRUG: Tiprogrel
DRUG: Tiprogrel
DRUG: Clopidogrel
DRUG: Ticagrelor

Sponsor

Tianjin Institute of Pharmaceutical Research Co., Ltd